#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Odborné časopisy / PLOS Pathogens / 2014 - 5

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development

English version České info

article has not abstract

Vyšlo v časopise: HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development. PLoS Pathog 10(5): e32767. doi:10.1371/journal.ppat.1004073
Kategorie: Pearls
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1004073

Souhrn

article has not abstract

Zdroje

1. PlotkinS (2010) Correlates of protection induced by vaccination. Clin Vaccine Immunol 17: 1055–1065.

2. WeiX, DeckerJM, WangS, HuiH, KappesJC, et al. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307–312.

3. McElrathMJ, HaynesBF (2010) Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33: 542–554.

4. MascolaJR, HaynesBF (2013) HIV-1 neutralizing antibodies: understanding nature's pathways. Immunol Rev 254: 225–44.

5. HessellAJ, PoignardP, HunterM, HangartnerL, TehraniDM, et al. (2009) Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 15: 951–954.

6. HessellAJ, RakaszEG, PoignardP, HangartnerL, LanducciG, et al. (2009) Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog 5: e1000433.

7. MoldtB, RakaszEG, SchultzN, Chan-HuiPY, SwiderekK, et al. (2012) Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc Natl Acad Sci USA 109: 18921–18925.

8. BarouchDH, WhitneyJB, MoldtB, KleinF, OliveiraTY, et al. (2013) Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature 503: 224–228.

9. BalazsAB, ChenJ, HongCM, RaoDS, YangL, et al. (2012) Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481: 81–84.

10. BonsignoriM, AlamSM, LiaoHX, VerkoczyL, TomarasGD, et al. (2012) HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design. Trends Microbiol 20: 532–539.

11. StamatatosL, MorrisL, BurtonDR, MascolaJR (2009) Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? Nature Med 15: 866–870.

12. HaynesBF, FlemingJ, St ClairEW, KatingerH, StieglerG, et al. (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308: 1906–1908.

13. HaynesBF, MoodyMA, VerkoczyL, KelsoeG, AlamSM (2005) Antibody polyspecificity and neutralization of HIV-1: a hypothesis. Hum Antibodies 14: 59–67.

14. WardemannH, YurasovS, SchaeferA, YoungJW, MeffreE, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301: 1374–1377.

15. VerkoczyL, KelsoeG, MoodyMA, HaynesBF (2011) Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies. Curr Opin Immunol 23: 383–390.

16. MeffreE, MililiM, Blanco-BetancourtC, AntunesH, NussenzweigMC, et al. (2001) Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest 108: 879–886.

17. Von BoehmerH, MelchersF (2010) Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol 11: 176–183.

18. VerkoczyL, DiazM, HollTM, OuyangY-B, Bouton-VervilleH, et al. (2010) Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc Natl Acad Sci USA 107: 181–186.

19. VerkoczyL, ChenY, Bouton-VervilleH, ZhangJ, DiazM, et al. (2011) Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH×VL knockin mice reveals multiple tolerance controls. J Immunol 187: 3785–3797.

20. ChenY, ZhangJ, HwangK-K, Bouton-VervilleH, XiaS-M, et al. (2013) Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J Immunol 191: 1260–1275.

21. Doyle-CooperC, HudsonKE, CooperAB, OtaT, SkogP, et al. (2013) Immune Tolerance Negatively Regulates B Cells in Knock-In Mice Expressing Broadly Neutralizing HIV Antibody 4E10. J Immunol 191: 3186–3191.

22. FintonKA, LarimoreK, LarmanHB, FriendD, CorrentiC, et al. (2013) Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10. PLoS Pathog 9: e1003639.

23. AlamSM, LiaoHX, DennisonSM, JaegerF, ParksR, et al. (2011) Differential reactivity germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation. J Virol 85: 11725–11731.

24. ZhangJ, AlamSM, Bouton-VervilleH, ChenY, NewmanA, et al. (2014) Modulation of non-neutralizing gp41 responses by an MHC-restricted TH epitope overlapping those of MPER broad neutralizing antibodies. J Immunol 192: 1693–1706.

25. LiaoHX, ChenX, MunshawS, ZhangR, MarshallDJ, et al. (2011) Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J Exp Med 208: 2237–2249.

26. HaynesBF, KelsoeG, HarrisonSC, KeplerTB (2012) B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotech 30: 423–433.

27. NemazeeD, BurkiK (1989) Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 337: 562–566.

28. EriksonJ, RadicMZ, CamperSA, HardyRR, CarmackC, et al. (1991) Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature 349: 331–334.

29. HartleySB, CrosbieJ, BrinkR, KantorAB, BastenA, et al. (1991) Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens. Nature 353: 765–769.

30. GoodnowCC (1992) Transgenic mice and analysis of B-cell tolerance. Ann Rev Immunol 10: 489–518.

31. YangG, HollTM, LiuY, LiX, NicelyN, et al. (2013) Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med 210: 241–256.

32. VerkoczyL, ChenY, ZhangJ, Bouton-VervilleH, NemanA, et al. (2013) Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: selection against MPER-associated autoreactivity limits T-dependent responses. J Immunol 191: 2538–2550.

33. HuangJ, OfekG, LaubL, LouderMK, Doria-RoseNA, et al. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491: 406–412.

34. OtaT, Doyle-CooperC, CooperAB, DooresKJ, Aoki-OtaM, et al. (2013) B cells from Knock-in Mice Expressing Broadly Neutralizing HIV Antibody b12 Carry an Innocuous B Cell Receptor Responsive to HIV Vaccine Candidates. J Immunol 191: 3179–85.

35. LiaoH-X, LynchR, ZhouZ, GaoG, AlamSM, et al. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496: 469–76.

36. OtaT, Doyle-CooperC, CooperAB, HuberM, FalkowskaE, et al. (2012) Anti-HIV B Cell Lines as Candidate Vaccine Biosensors. J Immunol 189: 4816–4824.

37. ChenJ, LansfordR, StewartV, YoungF, AltFW (1993) RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. Proc Natl Acad Sci USA 90: 4528–4532.

38. BatistaFD, NeubergerMS (1998) Affinity Dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity 8: 751–759.

39. KleinF, DiskinR, ScheidJF, GaeblerC, MouquetH, et al. (2013) Somatic mutations of the immunoglobulin framework are generally required for broad and potent neutralization. Cell 153: 126–138.

40. MoorePL, GrayES, WibmerCK, BhimanJN, NonyaneM, et al. (2012) Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape. Nat Med 18: 1688–1692.

41. HootS, McGuireAT, CohenKW, StrongRK, HangartnerL, et al. (2013) Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bnAbs. PLoS Pathog 9: e1003106.

42. AlamSM, MorelliM, DennisonSM, LiaoHX, ZhangR, et al. (2009) Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc Natl Acad Sci USA 106: 20234–20239.

43. MouquetH, ScheidJF, ZollerMJ, KrogsgaardM, OttRG, et al. (2010) Polyreactivity increases the apparaent affinity of anti-HIV antibodies by hereoligation. Science 467: 591–595.

44. JardineJ, JulienJ-P, MenisS, OtaT, KalyuzhniyO, et al. (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science 340: 711–716.

45. McGuireAT, HootS, DreyerAM, LippyA, StuartA, et al. (2013) Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J Exp Med 210: 655–663.

46. DormitzerPR, GrandiG, RappuoliR (2012) Structural vaccinology starts to deliver. Nat Rev Microbiol 10: 807–813.

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium
Článek Surveillance for Emerging Biodiversity Diseases of Wildlife
Článek The Emerging Role of Urease as a General Microbial Virulence Factor
Článek PARV4: An Emerging Tetraparvovirus
Článek Epigenetic Changes Modulate Schistosome Egg Formation and Are a Novel Target for Reducing Transmission of Schistosomiasis
Článek The Human Adenovirus E4-ORF1 Protein Subverts Discs Large 1 to Mediate Membrane Recruitment and Dysregulation of Phosphatidylinositol 3-Kinase
Článek A Multifactorial Role for Malaria in Endemic Burkitt's Lymphoma Pathogenesis
Článek Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease
Článek Cathepsin-L Can Resist Lysis by Human Serum in
Článek Epstein-Barr Virus Down-Regulates Tumor Suppressor Expression
Článek BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner
Článek The Evolutionarily Conserved Mediator Subunit MDT-15/MED15 Links Protective Innate Immune Responses and Xenobiotic Detoxification
Článek Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection
Článek T Cell Inactivation by Poxviral B22 Family Proteins Increases Viral Virulence
Článek Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model
Článek HIV and HCV Activate the Inflammasome in Monocytes and Macrophages via Endosomal Toll-Like Receptors without Induction of Type 1 Interferon
Článek Virus and Autoantigen-Specific CD4+ T Cells Are Key Effectors in a SCID Mouse Model of EBV-Associated Post-Transplant Lymphoproliferative Disorders
Článek Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis
Článek Squalene Synthase As a Target for Chagas Disease Therapeutics
Článek The Contribution of Viral Genotype to Plasma Viral Set-Point in HIV Infection
Článek Combined Systems Approaches Reveal Highly Plastic Responses to Antimicrobial Peptide Challenge in
Článek Anthrax Lethal Factor as an Immune Target in Humans and Transgenic Mice and the Impact of HLA Polymorphism on CD4 T Cell Immunity
Článek Ly49C-Dependent Control of MCMV Infection by NK Cells Is -Regulated by MHC Class I Molecules
Článek Two Novel Human Cytomegalovirus NK Cell Evasion Functions Target MICA for Lysosomal Degradation
Článek A Large Family of Antivirulence Regulators Modulates the Effects of Transcriptional Activators in Gram-negative Pathogenic Bacteria
Článek Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
Článek Malaria Parasite Infection Compromises Control of Concurrent Systemic Non-typhoidal Infection via IL-10-Mediated Alteration of Myeloid Cell Function
Článek A Role for in Higher Order Structure and Complement Binding of the Capsule
Článek Hip1 Modulates Macrophage Responses through Proteolysis of GroEL2
Článek CD8 T Cells from a Novel T Cell Receptor Transgenic Mouse Induce Liver-Stage Immunity That Can Be Boosted by Blood-Stage Infection in Rodent Malaria
Článek Phosphorylation of KasB Regulates Virulence and Acid-Fastness in
Článek HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Článek A Novel Mechanism Inducing Genome Instability in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells
Článek Structural and Biochemical Characterization Reveals LysGH15 as an Unprecedented “EF-Hand-Like” Calcium-Binding Phage Lysin
Článek Hepatitis C Virus Cell-Cell Transmission and Resistance to Direct-Acting Antiviral Agents
Článek Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G
Článek TNFα and IFNγ but Not Perforin Are Critical for CD8 T Cell-Mediated Protection against Pulmonary Infection
Článek Large Scale RNAi Reveals the Requirement of Nuclear Envelope Breakdown for Nuclear Import of Human Papillomaviruses
Článek The Cytoplasmic Domain of Varicella-Zoster Virus Glycoprotein H Regulates Syncytia Formation and Skin Pathogenesis
Článek A New Class of Multimerization Selective Inhibitors of HIV-1 Integrase
Článek Are We There Yet? The Smallpox Research Agenda Using Variola Virus
Článek High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases
Článek Dynamic Functional Modulation of CD4 T Cell Recall Responses Is Dependent on the Inflammatory Environment of the Secondary Stimulus
Článek Bacterial Superantigens Promote Acute Nasopharyngeal Infection by in a Human MHC Class II-Dependent Manner
Článek Follicular Helper T Cells Promote Liver Pathology in Mice during Infection
Článek A Nasal Epithelial Receptor for WTA Governs Adhesion to Epithelial Cells and Modulates Nasal Colonization
Článek Unexpected Role for IL-17 in Protective Immunity against Hypervirulent HN878 Infection
Článek Human Cytomegalovirus Fcγ Binding Proteins gp34 and gp68 Antagonize Fcγ Receptors I, II and III
Článek Expansion of Murine Gammaherpesvirus Latently Infected B Cells Requires T Follicular Help
Článek Venus Kinase Receptors Control Reproduction in the Platyhelminth Parasite
Článek Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses
Článek The Downregulation of GFI1 by the EZH2-NDY1/KDM2B-JARID2 Axis and by Human Cytomegalovirus (HCMV) Associated Factors Allows the Activation of the HCMV Major IE Promoter and the Transition to Productive Infection
Článek Inactivation of Fructose-1,6-Bisphosphate Aldolase Prevents Optimal Co-catabolism of Glycolytic and Gluconeogenic Carbon Substrates in
Článek New Insights into Rotavirus Entry Machinery: Stabilization of Rotavirus Spike Conformation Is Independent of Trypsin Cleavage
Článek Prophenoloxidase Activation Is Required for Survival to Microbial Infections in
Článek SslE Elicits Functional Antibodies That Impair Mucinase Activity and Colonization by Both Intestinal and Extraintestinal Strains
Článek Timed Action of IL-27 Protects from Immunopathology while Preserving Defense in Influenza
Článek The PhoP-Dependent ncRNA Mcr7 Modulates the TAT Secretion System in
Článek Cellular Superspreaders: An Epidemiological Perspective on HIV Infection inside the Body
Článek The Inflammasome Pyrin Contributes to Pertussis Toxin-Induced IL-1β Synthesis, Neutrophil Intravascular Crawling and Autoimmune Encephalomyelitis
Článek Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome
Článek Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle
Článek Co-assembly of Viral Envelope Glycoproteins Regulates Their Polarized Sorting in Neurons
Článek Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
Článek Dual-Site Phosphorylation of the Control of Virulence Regulator Impacts Group A Streptococcal Global Gene Expression and Pathogenesis
Článok vyšiel v časopise

PLOS Pathogens

2014 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.
Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#